Neuro
Neuro makes functional gum and mints infused with nootropic ingredients like caffeine, L-theanine, and B vitamins for energy, focus, and calm.
Est. Valuation
$600M
$600,000,000 · 5× ARR estimate
Monthly Revenue (MRR)
$10M
$10,000,000/mo
Annual Revenue (ARR)
$120M
$120,000,000/yr
Founded
2015
Neuro Revenue History
Revenue history for Neuro from 2025 to 2026.
| Year | MRR | ARR | YoY Growth | Source |
|---|---|---|---|---|
| 2025 | $10,000,000 | $100,000,000 | — | Feb 2025 |
How Neuro Makes Money
Neuro Funding
Neuro is fully bootstrapped with no outside funding. The company has grown to $120,000,000 ARR organically.
Neuro Founders
Ryan Chen
Co-founder & CFO
Kent Yoshimura
Co-founder & CEO
Neuro FAQ
How much does Neuro make?
What is Neuro's valuation?
Who founded Neuro?
Is Neuro bootstrapped?
What does Neuro do?
Companies Similar to Neuro
SaaS companies with similar tags and business models.
How We Estimate Neuro's Revenue & Valuation
Profitable tracks revenue, valuation, and other key metrics for thousands of companies using a layered confidence model. Each revenue figure on this page is tagged with one of three confidence levels:
- Verified — directly confirmed via Stripe integration or audited filings.
- Self-reported — numbers publicly shared by the founder on X, blog posts, or interviews.
- Estimated — derived from publicly available signals (traffic, employee count, pricing, comparables).
Valuation follows a hierarchy: public companies use the live market cap; private companies with disclosed funding rounds use the last reported valuation; otherwise we apply a conservative 5× ARR multiple as an estimate. Multiples vary by business model — SaaS typically sits 5–7×, profitable bootstrapped operations 3–5×, consumer brands 1–3×, marketplaces 8–12×.
These are estimates, not official figures. Official numbers — when available — will always override estimates.